Preliminary Evaluation of the Safety and Immunogenicity of an Antimalarial Vaccine Candidate Modified Peptide (IMPIPS) Mixture in a Murine Model

<div>Histological section of the myocardium on day 70, stained with haematoxylin-eosin: (a) histology for the normal myocardium in a mouse treated with physiological saline solution (100x); (b) section of the myocardium from a mouse belonging to the group immunised with IMPIPS+adjuvant; microcirculatory changes related to moderate vascular congestion were observed (100x).</div>

Journal of Immunology Research

fig3

Figure 3

Figure 3: Preliminary Evaluation of the Safety and Immunogenicity of an Antimalarial Vaccine Candidate Modified Peptide (IMPIPS) Mixture in a Murine Model 

Figure 3 | Preliminary Evaluation of the Safety and Immunogenicity of an Antimalarial Vaccine Candidate Modified Peptide (IMPIPS) Mixture in a Murine Model 